Immediate Impact
1 by Nobel laureates 65 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Regulatory mechanisms of PD-1/PD-L1 in cancers
2024 Standout
Works of Rémi Veillon being referenced
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study
2017
Hyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO)
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rémi Veillon | 418 | 528 | 9 | 148 | 68 | 705 | |
| Wei Jiang | 291 | 427 | 93 | 181 | 84 | 848 | |
| Charles Ricordel | 506 | 446 | 62 | 192 | 73 | 747 | |
| K. Park | 441 | 546 | 17 | 144 | 54 | 763 | |
| Dengfeng Ren | 332 | 500 | 40 | 175 | 43 | 773 | |
| Jian Zhang | 225 | 366 | 48 | 226 | 57 | 684 | |
| Matteo Brighenti | 305 | 610 | 23 | 177 | 38 | 839 | |
| Myung Hee Chang | 242 | 376 | 16 | 117 | 49 | 698 | |
| Weiguo Su | 318 | 344 | 12 | 221 | 65 | 664 | |
| Michele Prisciandaro | 254 | 547 | 82 | 147 | 46 | 723 | |
| Anastasios Dimou | 306 | 474 | 71 | 195 | 67 | 781 |
All Works
Loading papers...